Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cyclacel Pharmaceuticals

8.24
+0.41505.31%
Post-market: 8.00-0.2350-2.85%19:50 EDT
Volume:97.37K
Turnover:807.55K
Market Cap:18.44M
PE:-0.85
High:8.82
Open:7.78
Low:7.74
Close:7.82
52wk High:597.60
52wk Low:3.08
Shares:2.24M
Float Shares:966.60K
Volume Ratio:2.04
T/O Rate:10.07%
Dividend:0.00
Dividend Rate:0.01%
EPS(TTM):-9.6620
EPS(LYR):-502.4648
ROE:-276.80%
ROA:-102.83%
PB:5.08
PE(LYR):-0.02

Loading ...

Company Profile

Company Name:
Cyclacel Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
1996
Employees:
12
Office Location:
Level 10,Tower 11,Avenue 5, No. 8,Jalan Kerinchi,Kuala Lumpur,Wilayah Persekutuan,Malaysia
Zip Code:
592000
Fax:
- -
Introduction:
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases in the United States, the United Kingdom, and internationally. The company's lead product includes fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors and hematological malignancies, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and Plogosertib, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced solid tumors and hematological malignancies. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. The company was founded in 1996 and is headquartered in Berkeley Heights, New Jersey.

Directors

Name
Position
Datuk Doris Wong
Chief Executive Officer and Executive Director
Inigo Angel Laurduraj
Independent Director
Kiu Cu Seng
Chief Financial Officer, Executive Director and Secretary
Kwang Fock Chong
Independent Director
Satis Waran Nair Krishnan
Independent Director

Shareholders

Name
Position
Datuk Doris Wong
Chief Executive Officer and Executive Director
Kiu Cu Seng
Chief Financial Officer, Executive Director and Secretary